HypoSti.CAR-HER2 T
/ Chinese PLA General Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
April 22, 2025
CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: Chinese PLA General Hospital
New P1/2 trial • Solid Tumor
December 12, 2023
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=30 | Recruiting | Sponsor: Chinese PLA General Hospital | Not yet recruiting ➔ Recruiting | Initiation date: Jul 2023 ➔ Oct 2023
CAR T-Cell Therapy • Enrollment open • Metastases • Trial initiation date • Oncology • Solid Tumor • HER-2
May 31, 2023
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: Chinese PLA General Hospital | Initiation date: Feb 2023 ➔ Jul 2023
CAR T-Cell Therapy • Metastases • Trial initiation date • Oncology • Solid Tumor • HER-2
January 12, 2023
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: Chinese PLA General Hospital
CAR T-Cell Therapy • Metastases • New P1/2 trial • Oncology • Solid Tumor • HER-2
1 to 4
Of
4
Go to page
1